Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1153)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 27, 2024 (publication date) through Sep 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huynh T, Bui DM, Zhou TX, Hu KQ. Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years. World J Hepatol 2024; 16(7): 1009-1017 [PMID: 39086529 DOI: 10.4254/wjh.v16.i7.1009] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i7/1009.htm |
| Number | Citing Articles |
| 1 |
Balazs Fülöp, Janett Fischer, Magdalena Hahn, Albrecht Böhlig, Madlen Matz-Soja, Thomas Berg, Florian van Bömmel. Prospective Analysis of Safety and Efficacy of Tenofovir Alafenamide Fumarate (TAF) in European Real-World Patients with Chronic Hepatitis B: A Single-Centre Real-Word Cohort Study. Pathogens 2024; 13(9): 820 doi: 10.3390/pathogens13090820
|